NCT06620445

Brief Summary

The study will be conductued at the Pediatric Oncology Department of the Children's Hospital, PIMS Islamabad, over the peroid of six months. This single-blinded, two-arm RCT study will involve 80 children aged 8 to 16 years with maligancies recieving chemotherapy. Participants will be randomly allocated to either interventional or CBT group which will recieve weekly five sessions of Cognitive Behaviour Therapy (CBT) or the control group, which will recieve the usual care. CBT session will be contducted by Clinical Psychologist will last 30-35 minutes. Outcomes will be measured at Baseine and one month post intervention using Revised Child Anxiety and Depression Scale (RCADS) and Pediatric Quality of Life Generic Core Score 4.0.

Trial Health

43
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
80

participants targeted

Target at P50-P75 for not_applicable

Timeline
Completed

Started Oct 2024

Shorter than P25 for not_applicable

Geographic Reach
1 country

1 active site

Status
not yet recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

September 10, 2024

Completed
21 days until next milestone

First Posted

Study publicly available on registry

October 1, 2024

Completed
9 days until next milestone

Study Start

First participant enrolled

October 10, 2024

Completed
4 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

February 10, 2025

Completed
5 months until next milestone

Study Completion

Last participant's last visit for all outcomes

June 30, 2025

Completed
Last Updated

October 1, 2024

Status Verified

September 1, 2024

Enrollment Period

4 months

First QC Date

September 10, 2024

Last Update Submit

September 26, 2024

Conditions

Keywords

Psychological InterventionPediatric Cancer

Outcome Measures

Primary Outcomes (1)

  • Revised Child Anxiety and Depression Scale (RCADS)

    The RCADS is a standardized, self reported scale measuring anxiety and depression symptoms among children aged 8-18 years.

    Baseline (before the intervention) and one month post intervention (after the five weekly sessions of CBT)

Secondary Outcomes (1)

  • Pediatric QoL

    Baseline and one month post intervention

Study Arms (2)

Interventional Group

EXPERIMENTAL

The Intervention or CBT group included 40 children aged 8-16 years with malignancies recieving chemotherapy. They will recieve weekly five sessions of CBT (30-35 minutes per session)

Behavioral: Interventiion or CBT Group

Control or Usual Care Group

NO INTERVENTION

The Control or No Intervention Group also known as Comparision Group or Usual Group will recieve the standard care or usual care for their condition. It will serve as a baseline for the CBT or Intervention Group.

Interventions

This RCT aims to evaluate the effect of Cognitive Behavioral Therapy (CBT) compared to usual care (UC) in pediatric oncology patients. We hypothesize that those receiving CBT will report lower depression and anxiety and improved QoL six months post-enrollment.

Also known as: Cognitive or Pschological Intervention
Interventional Group

Eligibility Criteria

Age8 Years - 16 Years
Sexall
Healthy VolunteersNo
Age GroupsChild (0-17)

You may qualify if:

  • Children aged 16-18 years
  • Diagnosed with malignancy
  • Recieving chemotherapy at the Pediatric Oncology Department of PIMS Islamabad
  • Able to understand and participate in CBT sessions
  • Parent/Caregiver consent and child assent
  • Exlusion Criteria:
  • Children with severe cognitive impairment or intellectual disability
  • Children with a comorbid medical conditions
  • Children whose parents or caregivers are unable to provide consent

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Muhammad Wasim Khan

Islamabad, 44000, Pakistan

Location

MeSH Terms

Conditions

Depressive Disorder, MajorNeoplasms

Condition Hierarchy (Ancestors)

Depressive DisorderMood DisordersMental Disorders

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
PARTICIPANT
Masking Details
Participants (Children/Guaddians or Parents) are unaware of which group they are assigned (CBT group or usual care group). Researcher are aware of the group assignments.
Purpose
SUPPORTIVE CARE
Intervention Model
PARALLEL
Model Details: This single-blinded, two-arm randomized controlled trial will involve 80 children aged 8-16 with malignancies receiving chemotherapy. Participants will be randomly assigned to either the experimental group, which will receive five weekly sessions of cognitive-behavioral intervention, or the control group, which will receive usual care. Each intervention session will last 30-35 minutes. Outcomes will be measured at baseline and one-month post-intervention using the Revised Child Anxiety and Depression Scale and Pediatric Quality of Life Inventory Generic Core Score 4.0.
Sponsor Type
OTHER GOV
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Dr. Muhammad Wasim Khan

Study Record Dates

First Submitted

September 10, 2024

First Posted

October 1, 2024

Study Start

October 10, 2024

Primary Completion

February 10, 2025

Study Completion

June 30, 2025

Last Updated

October 1, 2024

Record last verified: 2024-09

Data Sharing

IPD Sharing
Will not share

Demographic, Clinical and Treatment related Information of the Participants

Locations